UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
______________________________________________________________________
 
FORM 6-K
 
______________________________________________________________________
 
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of November 2019
 
______________________________________________________________________

Commission File Number: 001-38067
 
______________________________________________________________________

Verona Pharma plc
(Translation of registrant's name into English)
 
 ______________________________________________________________________

3 More London Riverside
London SE1 2RE UK
+44 203 283 4200
(Address of principal executive office)
 
  ______________________________________________________________________
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
 
 

 






INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K


On November 14, 2019, Verona Pharma plc (the "Company") issued a press release reporting the purchase of shares by Dr. David Ebsworth, Chairman of the Company (the Person Discharging Managerial Responsibilities ("PDMR") announcement, the ("PDMR Announcement")).

The PDMR Announcement is furnished herewith as Exhibit 1 to this Report on Form 6-K.



EXHIBIT INDEX
 
 
 
 
Exhibit
No.
 
Description
 
 
1
 



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 
 
 
 
 
 
 
 
 
 
VERONA PHARMA PLC
 
 
 
 
Date: November 22, 2019
 
 
By:
 
/s/ Claire Poll
 
 
 
 
 
Name:
 
Claire Poll
 
 
 
 
 
Title:
 
Legal Counsel
 
 
 
 

    


Verona Pharma (NASDAQ:VRNA)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Verona Pharma Charts.
Verona Pharma (NASDAQ:VRNA)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Verona Pharma Charts.